Literature DB >> 19018216

Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.

So Shan Mak1, Winnie Yeo, Yik Mun Lee, Kwok Fai Mo, Ka Yin Tse, Sut Mun Tse, Fung Ping Ho, Wing Hong Kwan.   

Abstract

BACKGROUND: The incidence rate of breast cancer is rising rapidly in Hong Kong. Lymphedema is a serious long-term complication of breast cancer surgery and radiation therapy.
OBJECTIVE: The objectives of this study were to evaluate risk factors associated with the development of lymphedema for patients with breast cancer who have had an axillary lymph node dissection and to explore potential factors associated with moderate to severe lymphedema.
METHODS: This was a matched case-control study of 202 women undergoing a unilateral axillary dissection for breast cancer, consisting of 101 cases with lymphedema and 101 controls who matched cases in terms of surgery date, axillary radiotherapy, and cancer stage. Arm circumferences were measured to determine presence and severity of lymphedema. Potential risk factors were collected by using clinical data and a questionnaire. A multiple logistic regression was used to obtain the adjusted odds ratios for potential risk factors for developing lymphedema. Exploratory analysis was also performed to identify factors associated with the development of moderate to severe lymphedema.
RESULTS: Adjusted odds ratios for the development of lymphedema were 3.80 (95% confidence interval [CI] = 1.84-7.87) for previous inflammation-infection and 1.06 (95% CI = 1.02-1.10) for an increase of 1 year of age at axillary dissection. On exploratory analysis, adjusted odds ratios for moderate to severe degree of lymphedema were 4.53 (95% CI = 2.16-9.52) for previous inflammation-infection, 2.94 (95% CI = 1.44-6.03) for operation on dominant arm, 1.11 (95% CI = 1.01-1.22) for an increase of 1 kg/m in body mass index (BMI) at recruitment, and 1.05 (95% CI = 1.01-1.10) for an increase of 1 year of age at recruitment time. DISCUSSION: Previous inflammation-infection and advanced age at axillary dissection are risk factors associated with the initiation of lymphedema. Previous inflammation-infection, operation on the side of the dominant hand, obesity, and aging are potential risk factors associated with the aggravation of lymphedema. Greater BMI is still a risk factor for lymphedema progression even in a lower BMI population.

Entities:  

Mesh:

Year:  2008        PMID: 19018216     DOI: 10.1097/NNR.0b013e31818c3de2

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  28 in total

Review 1.  Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity.

Authors:  Kathryn H Schmitz; Marian L Neuhouser; Tanya Agurs-Collins; Krista A Zanetti; Lisa Cadmus-Bertram; Lorraine T Dean; Bettina F Drake
Journal:  J Natl Cancer Inst       Date:  2013-08-29       Impact factor: 13.506

2.  Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema.

Authors:  Ira L Savetsky; Jeremy S Torrisi; Daniel A Cuzzone; Swapna Ghanta; Nicholas J Albano; Jason C Gardenier; Walter J Joseph; Babak J Mehrara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-23       Impact factor: 4.733

Review 3.  Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.

Authors:  Mei R Fu
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Proactive approach to lymphedema risk reduction: a prospective study.

Authors:  Mei R Fu; Deborah Axelrod; Amber A Guth; Francis Cartwright; Zeyuan Qiu; Judith D Goldberg; June Kim; Joan Scagliola; Robin Kleinman; Judith Haber
Journal:  Ann Surg Oncol       Date:  2014-05-09       Impact factor: 5.344

5.  Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction.

Authors:  Mei R Fu; Yvette P Conley; Deborah Axelrod; Amber A Guth; Gary Yu; Jason Fletcher; David Zagzag
Journal:  Breast       Date:  2016-07-22       Impact factor: 4.380

6.  Five-year follow-up of treatment outcomes in patients with early-stage breast cancer and clinically negative axillary nodes treated with no lymph node dissection or axillary clearance.

Authors:  Daigo Yamamoto; Kanji Tanaka; Yu Tsubota; Noriko Sueoka; Tetsuji Shoji; Kayoko Kuwana; A-Hon Kwon
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-08-27

7.  Breast cancer survivors' experiences of lymphedema-related symptoms.

Authors:  Mei Rosemary Fu; Mary Rosedale
Journal:  J Pain Symptom Manage       Date:  2009-12       Impact factor: 3.612

8.  Retrospective trial of complete decongestive physical therapy for lower extremity secondary lymphedema in melanoma patients.

Authors:  Eli Carmeli; Roberto Bartoletti
Journal:  Support Care Cancer       Date:  2010-01-12       Impact factor: 3.603

9.  Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer.

Authors:  Chantal M Ferguson; Meyha N Swaroop; Nora Horick; Melissa N Skolny; Cynthia L Miller; Lauren S Jammallo; Cheryl Brunelle; Jean A O'Toole; Laura Salama; Michelle C Specht; Alphonse G Taghian
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

10.  Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery.

Authors:  Maria S Asdourian; Meyha N Swaroop; Hoda E Sayegh; Cheryl L Brunelle; Amir I Mina; Hui Zheng; Melissa N Skolny; Alphonse G Taghian
Journal:  J Clin Oncol       Date:  2017-10-04       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.